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Repair of a blunt traumatic inferior vena cava
laceration with commercially available endografts
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Endografts have recently been used in the trauma setting for arterial injuries in surgically inaccessible areas or in medically
unstable patients. There have been considerably fewer reports on the use of endografts for treatment of traumatic venous
injuries. We present the case of an endograft repair of a blunt, traumatic inferior vena cava injury in a patient deemed at
high risk for surgical repair. ( J Vasc Surg 2006;43:841-3.)Endografts have recently been used in the trauma set-
ting for arterial injuries in surgically inaccessible areas or in
medically unstable patients. Few reports have been pub-
lished on the use of endografts for treatment of traumatic
venous injuries. We present the case of a successful en-
dograft repair of a blunt, traumatic inferior vena cava injury
in a patient deemed at high risk for surgical repair.
CASE REPORT
A 62-year-old construction worker presented to the trauma
unit with complaints of neck and abdominal pain after sustaining a
blunt impact to his head and torso by a 1500-lb pallet. The primary
survey was remarkable for a completely oriented man with hypo-
tension of 80/50mmHg that normalized with 1 liter of crystalloid
administration. A secondary survey revealed an incomplete tetra-
paresis. Cervical and extremity radiographs showed a fracture at
C1-C2, a type 2 (grade 4) odontoid fracture with instability, and a
right tibial plateau fracture, respectively. An abdominal computed
tomography (CT) scan showed a hematoma at the third lumbar
interspace and findings suggestive of a disruption of the infrarenal
inferior vena cava (IVC) (Fig 1).
During the course of the resuscitation, the patient again
became hypotensive with ischemic changes on electrocardiogram
(ECG) and was dispositioned to the operating room for IVC repair
and cervical stabilization. After surgical tracheostomy, the right
common femoral vein was percutaneously accessed and cannulated
with a 6F sheath (Cook, Indianapolis, Ind) over a 0.035-inch
guidewire. Under C-arm (OEC 9800, GE Healthcare, Waukesha,
Wisc) fluoroscopy, a venogramwas performed that demonstrated a
laceration with extravasations of contrast below the renal veins at
the level of the third lumbar vertebrae interspace (Fig 2).
The 0.035-inch guidewire was exchanged for an Amplatz wire
and the 6F sheath was removed and replaced with an 18F sheath
(Cook, Indianapolis, Ind). The 18F sheath was used as a reference
to measure the IVC diameter, which was 2.5 cm during a Valsalva
maneuver. With the goal of oversizing 10% to 15%, two 28.5-mm
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ployed in the IVC under roadmap fluoroscopy, also during a
Valsalva maneuver (Fig 3). The second cuff required placement
because of persistent extravasations after deployment of the first
endograft. Heparin was not administered. Completion venogra-
phy showed complete exclusion of the IVC laceration with no
contrast extravasations (Fig 4).
A cutdown was performed, and a saphenous vein patch veno-
plasty was used to repair the femoral vein. Once the IVC repair was
completed, the cervical fractures were reduced and stabilized by
halo placement. Enzyme and ECG analysis over the next 48 hours
ruled out a myocardial infarction.
The remainder of his hospitalization consisted of treatment of
nosocomial pneumonia, his associated orthopedic injuries, and a
popliteal vein deep venous thrombosis, for which he was heparinized
and prescribed Coumadin (Bristol-Myers Squibb, Princeton, NJ).
He was discharged to rehabilitation on postoperative day 15. He
remains on Coumadin and has done well without difficulties. The
vena caval endograft has remained patent at 14 months, as evi-
denced by duplex ultrasound scan (Fig 5).
DISCUSSION
Injury to the IVC from abdominal trauma is life threat-
ening and carries a reported mortality of 40% to 80%.1-3
Operative repair has traditionally been the mainstay
method of repairing these injuries. Recent reports have
described repair of the IVC using endovascular techniques
after iatrogenic injuries.4,5 Fewer reports exist for the en-
dovascular repair of the IVC after traumatic injuries.6 This
is the first report, to our knowledge, to describe the use of
commercially available endografts to repair a traumatic IVC
laceration.
For endovascular IVC repair to be a viable treatment
option, three factors must exist: (1) readily available endo-
vascularly skilled practitioners, (2) appropriately equipped
operative imaging suites, and (3) versatile endografts. As
surgeons are traditionally the first to be notified of trau-
matic, life-threatening hemorrhage, endovascularly trained
surgeons in an endovascular operative setting likely would
be the ideal setting to attempt repairs of this nature.
Initial endovascular management of vena caval injuries
centered primarily on balloon tamponade combined with
either open7 or endovascular repair.5 Commercially avail-
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shown to be very useful in the repair of surgically inacces-
sible retrohepatic caval injury.4 They have also been used
with success in the treatment of traumatic thoracic disrup-
tions,8 thus underscoring the versatility of these endografts
that are present on the shelves of many hospitals. Because
they are readily available at most hospitals, they may rapidly
be used to treat caval injuries, oftentimes obviating the
need for endovascular hemorrhage control.
For this case, we selected the Gore endograft because of
our familiarity with its use. Advantages inherent with this
device’s usage in the trauma setting include its rapid de-
ployment and flexible profile. Had the IVC been too large
for successful wall apposition, we would have chosen a
Fig 1. An abdominal computed tomography scan shows a hema-
toma at the third lumbar interspace and findings suggestive of a
disruption of the infrarenal inferior vena (arrow).
Fig 2. An intraoperative venogram shows extravasations of con-
trast (arrow).larger endograft such as the Zenith (Cook Inc, Blooming-ton, Ind). We aimed to oversize the endograft 10% to 15%
based on the transverse diameter of the IVC obtained
during the Valsalva maneuver. Although no clinical data
exist, we believe that the lower pulse pressure and thinner
muscular layers present in the IVC compared with the aorta
warrants less oversizing than that recommended for aortic
endografting.
Anticoagulation therapy after venous stenting for ste-
nosis has been recommended.9 Because of the relative lack
of significant clinical reports, the proper anticoagulation
regimen after IVC endografting is unknown. Intuitively,
Fig 3. Postendograft deployment (arrow).
Fig 4. Completion venography.we believe that patency after endografting for lacerations
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continued to prescribe Coumadin to our patient based
upon experimental canine model evidence of greater pa-
tency after IVC endografting in those receiving warfarin
compared with controls.10 The role of antiplatelet therapy
has also not been established, but its use is suggested.9
We think this approach should be used when anatom-
ically appropriate for all patients with isolated IVC lacera-
tions. For patients with associated abdominal injuries re-
Fig 5. Duplex ultrasound scan at 14 months. The bracket dem-
onstrates the endografts.quiring laparotomy, IVC endograft placement beforeexploration may serve as an important means to reduce the
high mortality associated with the open repair of these
injuries. In conclusion, commercial endografts may be suc-
cessfully used in the repair of IVC injuries and should be
considered when possible in these individuals.
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